Summary of Study ST001247
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000834. The data can be accessed directly via it's Project DOI: 10.21228/M8W67P This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
| Study ID | ST001247 |
| Study Title | Longitudinal Characterization of the Fecal Metabolome in Dogs with Idiopathic Inflammatory Bowel Disease |
| Study Summary | Thirteen dogs diagnosed with idiopathic IBD, that previously failed to respond to treatment with elimination diets and metronidazole, were enrolled. Stool samples were collected from all dogs before initiating therapy with prednisone, after 3 and 8 weeks, and more than one year after beginning treatment. Thirteen healthy dogs were enrolled in the study as a control group. |
| Institute | Texas A&M University |
| Department | Department of Small Animal Clinical Sciences |
| Laboratory | Gastrointestinal Laboratory |
| Last Name | Pilla |
| First Name | Rachel |
| Address | 4474 TAMU |
| rpilla@cvm.tamu.edu | |
| Phone | 9798622861 |
| Submit Date | 2019-09-03 |
| Raw Data Available | Yes |
| Raw Data File Type(s) | cdf |
| Analysis Type Detail | MALDI-MS |
| Release Date | 2020-06-03 |
| Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Factors:
Subject type: Mammal; Subject species: Canis lupus familiaris (Factor headings shown in green)
| mb_sample_id | local_sample_id | Time point |
|---|---|---|
| SA090839 | Healthy_19_072 | 0WK | Status:HC | Treatment:none |
| SA090840 | Healthy_18_071 | 0WK | Status:HC | Treatment:none |
| SA090841 | Healthy_20_073 | 0WK | Status:HC | Treatment:none |
| SA090842 | Healthy_22_074 | 0WK | Status:HC | Treatment:none |
| SA090843 | Healthy_23_075 | 0WK | Status:HC | Treatment:none |
| SA090844 | Healthy_12_070 | 0WK | Status:HC | Treatment:none |
| SA090845 | Healthy_01_064 | 0WK | Status:HC | Treatment:none |
| SA090846 | Healthy_06_068 | 0WK | Status:HC | Treatment:none |
| SA090847 | Healthy_05_067 | 0WK | Status:HC | Treatment:none |
| SA090848 | Healthy_04_066 | 0WK | Status:HC | Treatment:none |
| SA090849 | Healthy_02_065 | 0WK | Status:HC | Treatment:none |
| SA090850 | Healthy_25_076 | 0WK | Status:HC | Treatment:none |
| SA090851 | Healthy_07_069 | 0WK | Status:HC | Treatment:none |
| SA090852 | BL_placebo_23_007 | 0WK | Status:IBD | Treatment:none |
| SA090853 | BL_placebo_28_008 | 0WK | Status:IBD | Treatment:none |
| SA090854 | BL_placebo_20_006 | 0WK | Status:IBD | Treatment:none |
| SA090855 | BL_placebo_19_005 | 0WK | Status:IBD | Treatment:none |
| SA090856 | BL_placebo_11_003 | 0WK | Status:IBD | Treatment:none |
| SA090857 | BL_placebo_14_004 | 0WK | Status:IBD | Treatment:none |
| SA090858 | BL_placebo_04_001 | 0WK | Status:IBD | Treatment:none |
| SA090859 | BL_placebo_35_009 | 0WK | Status:IBD | Treatment:none |
| SA090860 | BL_placebo_07_002 | 0WK | Status:IBD | Treatment:none |
| SA090861 | LT_placebo_14_053 | 1YR | Status:IBD | Treatment:none |
| SA090862 | LT_placebo_23_055 | 1YR | Status:IBD | Treatment:none |
| SA090863 | LT_placebo_28_056 | 1YR | Status:IBD | Treatment:none |
| SA090864 | LT_placebo_11_052 | 1YR | Status:IBD | Treatment:none |
| SA090865 | LT_placebo_19_054 | 1YR | Status:IBD | Treatment:none |
| SA090866 | 3WK_placebo_35_026 | 3WK | Status:IBD | Treatment:prednisone |
| SA090867 | 3WK_placebo_28_025 | 3WK | Status:IBD | Treatment:prednisone |
| SA090868 | 3WK_placebo_23_024 | 3WK | Status:IBD | Treatment:prednisone |
| SA090869 | 3WK_placebo_07_019 | 3WK | Status:IBD | Treatment:prednisone |
| SA090870 | 3WK_placebo_19_022 | 3WK | Status:IBD | Treatment:prednisone |
| SA090871 | 3WK_placebo_11_020 | 3WK | Status:IBD | Treatment:prednisone |
| SA090872 | 3WK_placebo_20_023 | 3WK | Status:IBD | Treatment:prednisone |
| SA090873 | 3WK_placebo_04_018 | 3WK | Status:IBD | Treatment:prednisone |
| SA090874 | 3WK_placebo_14_021 | 3WK | Status:IBD | Treatment:prednisone |
| SA090875 | 8WK_placebo_19_039 | 8WK | Status:IBD | Treatment:prednisone |
| SA090876 | 8WK_placebo_11_037 | 8WK | Status:IBD | Treatment:prednisone |
| SA090877 | 8WK_placebo_07_036 | 8WK | Status:IBD | Treatment:prednisone |
| SA090878 | 8WK_placebo_04_035 | 8WK | Status:IBD | Treatment:prednisone |
| SA090879 | 8WK_placebo_14_038 | 8WK | Status:IBD | Treatment:prednisone |
| SA090880 | 8WK_placebo_20_040 | 8WK | Status:IBD | Treatment:prednisone |
| SA090881 | 8WK_placebo_28_042 | 8WK | Status:IBD | Treatment:prednisone |
| SA090882 | 8WK_placebo_23_041 | 8WK | Status:IBD | Treatment:prednisone |
| SA090883 | 8WK_placebo_35_043 | 8WK | Status:IBD | Treatment:prednisone |
| Showing results 1 to 45 of 45 |
